International Stem Cell Corporation Announces Second Patient with Parkinson’s Disease Treated in Phase I Clinical Trial
International Stem Cell Corporation to Present Results of Neural Stem Cell Transplantation for Parkinson’s Disease
International Stem Cell Corporation and Rohto Pharmaceutical Enter Second Stage of Research Agreement
CORRECTION: Nextech3D.ai Provides Shareholder Update on Krafty Labs Acquisition and Announces $321,917 CEO Investment
Goldgroup Secures Ownership of the San Francisco Gold Mine Acquiring 100% of Molimentales del Noroeste, S.A. De C.V.
